🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
The main purpose of this study is to investigate the association between VE...
Status
Unknown
Location
Institute of Vision
Start Date
2008-01
Trial ID
NCT01655589
Anti-VEGF agents are given for a variety of previously untreatable eye dise...
Status
Completed
Location
St Olavs Hospital, Department of Ophthalmology
Start Date
2015-03
Trial ID
NCT02359149
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12
Trial ID
NCT03167164
Combination treatment with antiangiogenic agents and anti-programmed cell d...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2020-12-23
Trial ID
NCT04639284
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This was the cross-sectional study to assess the period prevalence of IOI i...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-07-15
Trial ID
NCT05146687
Treatments Being Tested
In this cross-sectional study of patients with wet AMD who received ≥1 anti...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-07-15
Trial ID
NCT05110209
Treatments Being Tested
Antagonists of the vascular endothelial growth factor (VEGF) pathway are ef...
Status
Completed
Location
The Retina Institute
Start Date
2011-09
Trial ID
NCT01428388
Treatments Being Tested
To determine if the regorafenib and nivolumab combination (RegoNivo) improv...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2021-05-05
Trial ID
NCT04879368
Treatments Being Tested